Dr. Joseph Marshall Bowen, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1296 E Polston Ave, Suite B, Post Falls, ID 83854 Phone: 208-457-7075 Fax: 208-457-7076 |
Dr. Joanne Halbrecht, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3773 W 5th Ave, Post Falls, ID 83854 Phone: 208-758-8893 |
Dr. Jonathan Jay Linthicum, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1296 E Polston Ave Ste C, Post Falls, ID 83854 Phone: 208-457-7075 |
Dr. Christopher Bateman Dewing, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1610 E Schneidmiller Ave, Post Falls, ID 83854 Phone: 208-618-6070 Fax: 208-618-8903 |
Dr. Roland Stanley Kent, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1641 E Polston Ave Ste 101, Post Falls, ID 83854 Phone: 208-457-4208 Fax: 208-457-4197 |
Dr. David Michael Glassman, MD Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Medicare Enrolled Practice Location: 1641 E Polston Ave Ste 101, Post Falls, ID 83854 Phone: 208-457-4208 Fax: 208-457-4197 |
Dr. Christopher Frederic Jessen, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5475 E Shoreline Dr, Post Falls, ID 83854 Phone: 208-777-7109 |
Dr. Daniel John Blizzard, MD Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Accepting Medicare Assignments Practice Location: 1641 E Polston Ave Ste 101, Post Falls, ID 83854 Phone: 208-457-4208 Fax: 208-457-4197 |
News Archive
For many years, the use of computer-assisted navigation has been touted as improving the positioning, sizing and alignment of replacement knee joints, resulting in greater durability of joints and overall improvement in patient movement. However, new research published in the Journal of Bone and Joint Surgery (JBJS) found no difference in knee function, alignment or durability/survivorship between joints positioned and completed with the help of computer navigation, and those replaced with conventional total knee arthroplasty (TKA) procedures.
Scientists in Australia are reporting development and testing in laboratory animals of a potential new material for diagnosing malignant melanoma, the most serious form of skin cancer. Their study is scheduled for the September 10 issue of the ACS' Journal of the Medicinal Chemistry, a bi-weekly publication.
Osteologix, Inc., a bio-pharmaceutical company announced today that the company will continue the clinical development for its osteoporosis drug, NB S101 (strontium malonate), in the United States and the rest of the world markets. Additionally, the company wants to recognize World Osteoporosis Day's significance and make more people aware of its research dedicated to improving the lives of people with osteoporosis.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-AT3, a subcutaneously administered RNAi therapeutic targeting antithrombin (AT) for the treatment of hemophilia and rare bleeding disorders (RBD), at the 55th Annual Meeting of the American Society of Hematology (ASH) held December 7 - 10, 2013 in New Orleans.
MedAssets, Inc. today announced that it has completed its acquisition of The Broadlane Group. The combination of MedAssets and Broadlane creates the industry's leading, end-to-end financial improvement partner that has saved billions for its healthcare provider customers, including more than $2.8 billion in documented and guaranteed supply chain savings.
› Verified 2 days ago